scholarly journals High fat diet induces brain insulin resistance and cognitive impairment in mice

Author(s):  
Vishal Kothari ◽  
Yuwen Luo ◽  
Talia Tornabene ◽  
Ann Marie O'Neill ◽  
Michael W Greene ◽  
...  
2014 ◽  
Vol 67 ◽  
pp. 79-87 ◽  
Author(s):  
Steven E. Arnold ◽  
Irwin Lucki ◽  
Bethany R. Brookshire ◽  
Gregory C. Carlson ◽  
Caroline A. Browne ◽  
...  

2017 ◽  
Vol 65 (13) ◽  
pp. 2719-2729 ◽  
Author(s):  
Jong Min Kim ◽  
Chang Hyeon Park ◽  
Seon Kyeong Park ◽  
Tae Wan Seung ◽  
Jin Yong Kang ◽  
...  

2020 ◽  
Vol 21 (10) ◽  
pp. 3428 ◽  
Author(s):  
Mei-Hsin Hsu ◽  
Jiunn-Ming Sheen ◽  
I-Chun Lin ◽  
Hong-Ren Yu ◽  
Mao-Meng Tiao ◽  
...  

To examine the effects of maternal resveratrol in rats borne to dams with gestational high-fat diet (HFD)/obesity with or without postnatal high-fat diet. We first tested the effects of maternal resveratrol intake on placenta and male fetus brain in rats borne to dams with gestational HFD/obesity. Then, we assessed the possible priming effect of a subsequent insult, male offspring were weaned onto either a rat chow or a HFD. Spatial learning and memory were assessed by Morris water maze test. Blood pressure and peripheral insulin resistance were examined. Maternal HFD/obesity decreased adiponectin, phosphorylation alpha serine/threonine-protein kinase (pAKT), sirtuin 1 (SIRT1), and brain-derived neurotrophic factor (BDNF) in rat placenta, male fetal brain, and adult male offspring dorsal hippocampus. Maternal resveratrol treatment restored adiponectin, pAKT, and BDNF in fetal brain. It also reduced body weight, peripheral insulin resistance, increased blood pressure, and alleviated cognitive impairment in adult male offspring with combined maternal HFD and postnatal HFD. Maternal resveratrol treatment restored hippocampal pAKT and BDNF in rats with combined maternal HFD and postnatal HFD in adult male offspring dorsal hippocampus. Maternal resveratrol intake protects the fetal brain in the context of maternal HFD/obesity. It effectively reduced the synergistic effects of maternal HFD/obesity and postnatal HFD on metabolic disturbances and cognitive impairment in adult male offspring. Our data suggest that maternal resveratrol intake may serve as an effective therapeutic strategy in the context of maternal HFD/obesity.


2019 ◽  
Vol 315 ◽  
pp. 1-8 ◽  
Author(s):  
Julia A. Hamer ◽  
Daniela Testani ◽  
Rodrigo B. Mansur ◽  
Yena Lee ◽  
Mehala Subramaniapillai ◽  
...  

Author(s):  
Domenico Nuzzo ◽  
Antonella Amato ◽  
Pasquale Picone ◽  
Simona Terzo ◽  
Giacoma Galizzi ◽  
...  

Obesity and metabolic disorders can be risk factors for the onset and development of neurodegenerative diseases. The aim of the present study was to investigate the protective effects on dysmetabolism and neurodegeneration of a natural dietary supplement (NDS), containing Curcuma longa, silymarin, guggul, chlorogenic acid and inulin, on the brains of high fat diet (HFD)-fed mice. A decreased expression of FACL-4, CerS-1 and CerS-4, reduced cholesterol concentration, increased IR expression and insulin signaling activation, were found in brains of NDS-treated HFD mice, suggesting that NDS is able to prevent brain lipid accumulation and central insulin resistance. In the brains of NDS-treated HFD mice, the levels of RNS, ROS and lipid peroxidation, the expression of p-ERK, H-Oxy, i-NOS, HSP60, NF-kB, GFAP, IL-1β, IL-6, and CD4 positive cell infiltration were lower than in untreated HFD mice, suggesting antioxidant and anti-inflammatory effects of NDS. The decreased expression of p-ERK and GFAP in NDS-treated HFD mice was confirmed by immunofluorescence. Lastly, a lower number of apoptotic nuclei was found in cortical sections of NDS-treated HFD. All these data indicate that NDS exerts neuroprotective effects in HFD mice by reducing brain fat accumulation, oxidative stress and inflammation and improving brain insulin resistance.


2021 ◽  
Vol 12 ◽  
Author(s):  
Qian Chen ◽  
Ting Cao ◽  
NaNa Li ◽  
Cuirong Zeng ◽  
Shuangyang Zhang ◽  
...  

Cognitive impairment is a shared abnormality between type 2 diabetes mellitus (T2DM) and many neurodegenerative and neuropsychiatric disorders, such as Alzheimer’s disease (AD) and schizophrenia. Emerging evidence suggests that brain insulin resistance plays a significant role in cognitive deficits, which provides the possibility of anti-diabetic agents repositioning to alleviate cognitive deficits. Both preclinical and clinical studies have evaluated the potential cognitive enhancement effects of anti-diabetic agents targeting the insulin pathway. Repurposing of anti-diabetic agents is considered to be promising for cognitive deficits prevention or control in these neurodegenerative and neuropsychiatric disorders. This article reviewed the possible relationship between brain insulin resistance and cognitive deficits. In addition, promising therapeutic interventions, especially current advances in anti-diabetic agents targeting the insulin pathway to alleviate cognitive impairment in AD and schizophrenia were also summarized.


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Cristobal L. Miranda ◽  
Lance A. Johnson ◽  
Oriane de Montgolfier ◽  
Valerie D. Elias ◽  
Lea S. Ullrich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document